• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 CRISPR-dot 纳米复合物靶向尿路致病性大肠杆菌 papG 基因降低 UPEC 的毒力。

Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC.

机构信息

Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi, India.

Department of Urology, University of Alabama at Birmingham, Hugh Kaul Genetics Building, Birmingham, AL, USA.

出版信息

Sci Rep. 2021 Sep 7;11(1):17801. doi: 10.1038/s41598-021-97224-4.

DOI:10.1038/s41598-021-97224-4
PMID:34493749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8423837/
Abstract

Urinary tract infections (UTI) are the most common infectious diseases in the world. It is becoming increasingly tough to treat because of emergence of antibiotic resistance. So, there is an exigency to develop novel anti-virulence therapeutics to combat multi-drug resistance pathogenic strains. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) discovery has revolutionized the gene editing technology for targeted approach. The greatest obstacle for CRISPR/Cas9 is cargo delivery systems and both viral and plasmid methods have disadvantages. Here, we report a highly efficient novel CRISPR based gene editing strategy, CRISPR-dots for targeting virulence factor Fimbrial Adhesion (papG gene), the bacterial adhesion molecule. Carbon quantum dots (CQD) were used as a delivery vehicle for Cas9 and gRNA into CFT073, a UPEC strain. CQDs were covalently conjugated to cas9 and papG-targeted guide RNA (gRNA) forming a nanocomplex CRISPR-dots (Cri-dots) as confirmed by DLS and transmission electron microscopy. Cri-dots-papG significantly targeted papG as demonstrated by decrease in the expression of papG.Further papG deficient UPEC had significantly reduced adherence ability and biofilm forming ability as demonstrated by fluorescence microscopy and scanning electron microscopy. Also, papG deficient UPEC had reduced virulence as shown by significantly increased survival of Caenorhabditis elegans (C. elegans) worms compared to UPEC. Our findings suggest that targeting of papG gene using Cri-dots nanocomplexes significantly reduced the pathogenicity of UPEC. Thus, Cri-dots nanocomplex offer a novel anti-bacterial strategy against multi-drug resistant UPEC.

摘要

尿路感染(UTI)是世界上最常见的传染病。由于抗生素耐药性的出现,治疗变得越来越困难。因此,迫切需要开发新型抗毒治疗方法来对抗多药耐药的病原菌。规律成簇间隔短回文重复序列(CRISPR)的发现彻底改变了靶向基因编辑技术。CRISPR/Cas9 的最大障碍是货物输送系统,病毒和质粒方法都有缺点。在这里,我们报告了一种基于 CRISPR 的高效新型基因编辑策略 CRISPR-dots,用于靶向毒力因子菌毛粘附(papG 基因),即细菌粘附分子。碳量子点(CQD)被用作 Cas9 和靶向 papG 的向导 RNA(gRNA)进入 UPEC 菌株 CFT073 的输送载体。CQD 通过 DLS 和透射电子显微镜被共价偶联到 Cas9 和靶向 papG 的 gRNA 上,形成纳米复合物 CRISPR-dots(Cri-dots)。Cri-dots-papG 显著靶向 papG,表现为 papG 表达下降。进一步研究表明,papG 缺失的 UPEC 粘附能力和生物膜形成能力显著降低,这通过荧光显微镜和扫描电子显微镜证实。此外,papG 缺失的 UPEC 的毒力降低,表现为秀丽隐杆线虫(C. elegans)存活显著增加与 UPEC 相比。我们的研究结果表明,使用 Cri-dots 纳米复合物靶向 papG 基因显著降低了 UPEC 的致病性。因此,Cri-dots 纳米复合物为对抗多药耐药的 UPEC 提供了一种新型的抗菌策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/6fbda289b165/41598_2021_97224_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/1e2dd505af91/41598_2021_97224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/80670e1dccdc/41598_2021_97224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/2b7bc27219b4/41598_2021_97224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/4a8d6c2cd41b/41598_2021_97224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/e8797e4ea189/41598_2021_97224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/ad838f8c6646/41598_2021_97224_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/6fbda289b165/41598_2021_97224_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/1e2dd505af91/41598_2021_97224_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/80670e1dccdc/41598_2021_97224_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/2b7bc27219b4/41598_2021_97224_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/4a8d6c2cd41b/41598_2021_97224_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/e8797e4ea189/41598_2021_97224_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/ad838f8c6646/41598_2021_97224_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d380/8423837/6fbda289b165/41598_2021_97224_Fig7_HTML.jpg

相似文献

1
Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC.利用 CRISPR-dot 纳米复合物靶向尿路致病性大肠杆菌 papG 基因降低 UPEC 的毒力。
Sci Rep. 2021 Sep 7;11(1):17801. doi: 10.1038/s41598-021-97224-4.
2
In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.蔓越莓的体内消耗对以FimH为主的尿路致病性大肠杆菌具有体外抗黏附活性:一项关于大果越橘提取物的体内、体外和体外联合研究
J Agric Food Chem. 2015 Oct 14;63(40):8804-18. doi: 10.1021/acs.jafc.5b03030. Epub 2015 Sep 29.
3
Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic .由尿路致病性菌毛粘附素产生的二聚体和三聚体融合蛋白
Front Cell Infect Microbiol. 2016 Oct 31;6:135. doi: 10.3389/fcimb.2016.00135. eCollection 2016.
4
Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.尿路致病性大肠埃希菌 FimH 在乳球菌中的表面展示:重组菌的体外特性及其在动物模型中的保护作用。
Microb Pathog. 2020 Apr;141:103974. doi: 10.1016/j.micpath.2020.103974. Epub 2020 Jan 8.
5
Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?抗黏附天然产物防治泌尿道致病性大肠杆菌:蔓越莓提取物能给我们带来什么启示?
J Ethnopharmacol. 2020 Jul 15;257:112889. doi: 10.1016/j.jep.2020.112889. Epub 2020 Apr 18.
6
Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli.泌尿道致病性大肠埃希菌中分子伴侣-usher 菌毛和卷曲菌毛的分布。
BMC Microbiol. 2024 Sep 14;24(1):344. doi: 10.1186/s12866-024-03472-5.
7
Uropathogenic Escherichia coli are less likely than paired fecal E. coli to have CRISPR loci.尿路致病性大肠杆菌比配对粪便大肠杆菌更不可能具有 CRISPR 基因座。
Infect Genet Evol. 2013 Oct;19:212-8. doi: 10.1016/j.meegid.2013.07.017. Epub 2013 Jul 25.
8
Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic isolates in relation to the antimicrobial resistance.与抗菌药物耐药性相关的尿源性分离株中黏附素编码基因的分布和生物膜形成能力。
Afr Health Sci. 2020 Mar;20(1):238-247. doi: 10.4314/ahs.v20i1.29.
9
Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.来自尿路感染的尿路致病性大肠杆菌分离株的分子分析
Infect Disord Drug Targets. 2019;19(3):322-326. doi: 10.2174/1871526518666181113091322.
10
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.组合小分子疗法可预防小鼠尿路致病性大肠埃希菌引起的导管相关性尿路感染。
Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25.

引用本文的文献

1
Disabling iron uptake and pilus assembly in uropathogenic Escherichia coli using CRISPR-Cas9: a step towards antivirulence therapy.利用CRISPR-Cas9使尿路致病性大肠杆菌中的铁摄取和菌毛组装失活:迈向抗毒力疗法的一步。
Antonie Van Leeuwenhoek. 2025 Jul 9;118(8):110. doi: 10.1007/s10482-025-02127-3.
2
Bacterial adhesion strategies and countermeasures in urinary tract infection.尿路感染中的细菌黏附策略与应对措施
Nat Microbiol. 2025 Mar;10(3):627-645. doi: 10.1038/s41564-025-01926-8. Epub 2025 Feb 10.
3
Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria.

本文引用的文献

1
Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.用于治疗尿路感染的抗生素替代治疗选择
Front Microbiol. 2020 Jul 3;11:1509. doi: 10.3389/fmicb.2020.01509. eCollection 2020.
2
Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.尿路感染:微生物发病机制、宿主-病原体相互作用和新的治疗策略。
Nat Rev Microbiol. 2020 Apr;18(4):211-226. doi: 10.1038/s41579-020-0324-0. Epub 2020 Feb 18.
3
Epidemiology of urological infections: a global burden.
关于对抗耐药细菌的CRISPR策略的当前知识
Antibiotics (Basel). 2024 Nov 27;13(12):1141. doi: 10.3390/antibiotics13121141.
4
CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions.对抗抗菌药物耐药性中的CRISPR-Cas系统:现状、潜力及未来方向
Infect Drug Resist. 2024 Nov 26;17:5229-5245. doi: 10.2147/IDR.S494327. eCollection 2024.
5
Delivery of functional Cas:DNA nucleoprotein complexes into recipient bacteria through a type IV secretion system.通过 IV 型分泌系统将功能性 Cas:DNA 核蛋白复合物递送至受体细菌中。
Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2408509121. doi: 10.1073/pnas.2408509121. Epub 2024 Oct 16.
6
Medical Device-Associated Biofilm Infections and Multidrug-Resistant Pathogens.医疗器械相关生物膜感染与多重耐药病原体
Pathogens. 2024 May 8;13(5):393. doi: 10.3390/pathogens13050393.
7
From Gene Editing to Biofilm Busting: CRISPR-CAS9 Against Antibiotic Resistance-A Review.从基因编辑到生物膜破解:CRISPR-CAS9 对抗抗生素耐药性——综述。
Cell Biochem Biophys. 2024 Jun;82(2):549-560. doi: 10.1007/s12013-024-01276-y. Epub 2024 May 3.
8
Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.近年来,人们对多药耐药性的分子机制的理解取得了一些进展,并提出了基于 CRISPR/Cas9 的基因组编辑的新方法来应对这一健康紧急情况。
Int J Nanomedicine. 2024 Feb 7;19:1125-1143. doi: 10.2147/IJN.S453566. eCollection 2024.
9
Chitosan-Coated Silver Nanoparticles Inhibit Adherence and Biofilm Formation of Uropathogenic .壳聚糖包覆的银纳米粒子抑制尿路致病性. 的黏附和生物膜形成。
ACS Infect Dis. 2024 Apr 12;10(4):1126-1136. doi: 10.1021/acsinfecdis.3c00229. Epub 2024 Jan 29.
10
The Potential Role of Persister Cells in Urinary Tract Infections.持留菌在尿路感染中的潜在作用。
Curr Urol Rep. 2023 Nov;24(11):541-551. doi: 10.1007/s11934-023-01182-5. Epub 2023 Nov 1.
尿路上皮感染的流行病学:全球负担。
World J Urol. 2020 Nov;38(11):2669-2679. doi: 10.1007/s00345-019-03071-4. Epub 2020 Jan 10.
4
Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics.基于非病毒纳米颗粒的 CRISPR/Cas9 治疗药物的递送策略。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 May;12(3):e1609. doi: 10.1002/wnan.1609. Epub 2019 Dec 2.
5
Involvement of NLRP3 and NLRC4 Inflammasome in Uropathogenic Mediated Urinary Tract Infections.NLRP3和NLRC4炎性小体在致病性尿路感染中的作用
Front Microbiol. 2019 Sep 3;10:2020. doi: 10.3389/fmicb.2019.02020. eCollection 2019.
6
PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells.大肠杆菌 PapG 亚型对人肾和膀胱尿路上皮细胞Globoside 系列糖鞘脂的特异性结合特性。
Glycobiology. 2019 Oct 21;29(11):789-802. doi: 10.1093/glycob/cwz059.
7
CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.CRISPR-cas 系统:微生物中的生物学功能及其在治疗抗微生物药物耐药性病原体中的应用。
Ann Clin Microbiol Antimicrob. 2019 Jul 5;18(1):21. doi: 10.1186/s12941-019-0317-x.
8
Impact of Proinflammatory Cytokines on the Virulence of Uropathogenic .促炎细胞因子对尿路致病性的毒力影响
Front Microbiol. 2019 May 9;10:1051. doi: 10.3389/fmicb.2019.01051. eCollection 2019.
9
Antibiotics versus biofilm: an emerging battleground in microbial communities.抗生素与生物膜:微生物群落中的新兴战场。
Antimicrob Resist Infect Control. 2019 May 16;8:76. doi: 10.1186/s13756-019-0533-3. eCollection 2019.
10
A flow cytometry method for bacterial quantification and biomass estimates in activated sludge.一种用于活性污泥中细菌定量和生物量估计的流式细胞术方法。
J Microbiol Methods. 2019 May;160:73-83. doi: 10.1016/j.mimet.2019.03.022. Epub 2019 Mar 26.